Utility Stocks Ameren, CenterPoint Power Up In Buy Zones Amid Volatile Stock Market

Utility stocks Ameren (AEE) and CenterPoint Energy (CNP) reached new highs this past week, as the stock market endured another round of volatility stemming from fears about artificial-intelligence disruption. Both stocks to watch are featured on Investor’s Business Daily’s New Highs list.

This week, the tech-heavy Nasdaq composite and the S&P 500 each logged solid losses. Thus, IBD set a recommended 40%-60% exposure threshold, indicating investors should be cautious with new breakouts and cut losses when sell signals emerge.

				    ↑
					X

This video file cannot be played.(Error Code: 102630)

								MarketSurge 2.0: Here's What To Expect From The New IBD Charting Platform
							

							

								See All Videos
							

						

					
					
						NOW PLAYING
						MarketSurge 2.0: Here's What To Expect From The New IBD Charting Platform

Utility Stocks To Watch: Ameren

St. Louis-headquartered Ameren provides electric and natural gas services to about 2.4 million electric customers and 900,000 natural gas customers in Missouri and Illinois. The company also provides power for data centers.

Shares rallied around 5% this past week, hitting new highs and moving further above a 106.73 buy point in a flat base, according to IBD MarketSurge. The 5% buy zone runs up to 112.07.

Ameren stock has a modest 82 out of a best-possible 99 IBD Composite Rating, according to IBD Stock Checkup, as well as an 89 EPS Rating.

CenterPoint Breaks Out

CenterPoint Energy advanced around 6% this week, moving decisively past a 40.50 flat-base entry.

Houston-based CenterPoint manages the infrastructure that delivers electricity and natural gas to roughly 7 million customers across several states, primarily in Texas.

Additionally, the company partners with companies such as Nvidia (NVDA) and Palantir Technologies (PLTR) to accelerate AI data center construction, permitting, and grid upgrades, addressing significant power demands.

In the latest quarter, CenterPoint earnings jumped 61% to 50 cents per share. Revenue climbed 7% to nearly $1.99 billion.

The stock’s RS line has climbed to its highest level since July. That’s a sign of outperformance compared with the broader market, particularly since the start of 2026.

**As Wall Street Whipsaws, What’s An Investor To Do? Start Here

**

Be sure to follow Scott Lehtonen on X at @IBD_SLehtonen for more on the Dow Jones Industrial Average and the stock market today.

YOU MAY ALSO LIKE:

Check Out IBD’s New Exposure Levels To Help You Stay In Step With The Market Trend

Top Growth Stocks To Buy And Watch

Learn How To Time The Market With IBD’s ETF Market Strategy

Find The Best Long-Term Investments With IBD Long-Term Leaders

Spot Buy Points And Sell Signals With MarketSurge Pattern Recognition